Additionally, the up-regulated expression of KAT2A was significantly correlated with poor clinical outcomes or high-risk factors such as overall survival, PFS, and higher a Gleason score, which suggested that KAT2A plays a critical role in the progression of PC and might act as a potential prognostic indicator for PC patients. The gene discussed is KAT2A; the disease is pachyonychia congenita.